Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Phase 1
Recruiting
- Conditions
- Unresectable Locally Advanced Esophageal CancerEsophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2023-12-18
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06173986
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
Not Applicable
Not yet recruiting
- Conditions
- Severe Emphysema
- Interventions
- Procedure: BTVA treatment plus optimal medical therapy (GOLD guidelines)
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06152107
Toripalimab Combined with Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
Phase 2
Recruiting
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Other: Cryoablation
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT06127303
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, China
🇨🇳Zhongshan Hospital, Fudan University, Shanghai, China
🇨🇳Shanghai Chest Hospital, Shanghai, Shanghai, China
RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy
Not Applicable
Not yet recruiting
- Conditions
- Surgical Procedure, Unspecified
- Interventions
- Procedure: ROBOTIC-ASSISTED ESOPHAGECTOMY
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06012214
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Metastatic Esophageal Squamous Cell CarcinomaEsophageal CancerEsophageal Squamous Cell Carcinoma
- Interventions
- Radiation: LDRT+CFRTDrug: ChemotherapyDrug: Immunotherapy
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT05978193
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, China
🇨🇳Shanghai Chest Hospital, Shanghai, China
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Conditions
- Small Cell Lung CarcinomaSmall Cell Lung Cancer Limited StageSmall Cell Lung Cancer Extensive StageSmall-cell Lung CancerSmall Cell Lung Cancer, Combined Type
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05945745
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Atrial FibrillationCathter AblationEndpoint
- Interventions
- Procedure: AF-termination GroupProcedure: Prespecified-ablation Group
- First Posted Date
- 2023-06-27
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 544
- Registration Number
- NCT05921734
- Locations
- 🇨🇳
Mu Qin, Shanghai, China
🇨🇳Shanghai Chest Hospital, Shanghai, China
AF Ablation for HF With Reduced EF
Not Applicable
Completed
- Conditions
- Persistent Atrial FibrillationHeart Failure With Reduced Ejection Fraction
- Interventions
- Procedure: AF ablationOther: medical therapy
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT05827172
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 1
Active, not recruiting
- Conditions
- NSCLC Stage IVNSCLC Stage IIIBNSCLC Stage IIIC
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05816499
- Locations
- 🇨🇳
lejie Cao, Hefei, Anhui, China
🇨🇳Jing Wang, Qingdao, Shandong, China
🇨🇳Shanghai Chest Hospital, Shanghai, Shanghai, China
The Effect of Toripalimab Plus Radiotherapy in Patients with Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
Phase 2
Recruiting
- Conditions
- NSCLC
- Interventions
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 124
- Registration Number
- NCT05798845
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath